A Multi-Centre Investigation Towards Reaching a Consensus on the Immunohistochemical Detection of ERβ in Archival Formalin-ﬁxed Paraffin Embedded Human Breast Tissue
- 88 Downloads
Estrogen receptor (ER) α is a well-established independent prognostic factor in breast cancer whose presence determines the clinical implications of adjuvant endocrine therapy. A second receptor, ERb has been described, and a number of studies have examined its expression in breast tissue. However elucidation of the role played by ERb has been hampered by published immunohistochemical studies employing a variety of protocols and scoring systems such that inter-laboratory comparisons are difficult. Here we present a multi-centre study designed to critically evaluate inter-laboratory differences in methodology. Six UK and Irish centres participated in this study. A small series of breast cancers were stained using centre-speciﬁc laboratory protocols and scored using both centrespeciﬁc and standard scoring protocols. There was generally poor agreement as to what constituted a positive or negative case when centre-speciﬁc scoring systems were used with less than half of all cases in agreement. Concordance was improved when a standard scoring system was used but varied according to threshold for positivity employed and primary antibody. Our results emphasise the need for further studies addressing the role of ERb to be based on a wider consensus on criteria for positivity. Ideally this should be based on calibration against clinical outcome.
Keywordsbreast cancer estrogen receptor β immunohistochemistry
Unable to display preview. Download preview PDF.
- Saunders, PT, Millar, MR, Williams, K, Macpherson, S, Harkiss, D, Anderson, RA, Orr, B, Groome, NP, Scobie, G, Fraser, HM 2000Differential expression of estrogen receptor -α and -β and androgen receptor in the ovaries of marmosets and humansBiol Rep6310981105Google Scholar
- Critchley, HO, Henderson, TA, Kelly, RW, Scobie, GS, Evans, LR, Groome, NP, Saunders, PT 2002Wild-type estrogen receptor (ERβ1) and the splice variant (ERβcx/β2) are both expressed within the human endometrium throughout the normal menstrual cycleJ Clin Endocrinol Metab8752655273CrossRefPubMedGoogle Scholar
- Stabile, LP, Davis, AL, Gubish, CT, Hopkins, TM, Luketich, JD, Christie, N, Finkelstein, S, Siegfried, JM 2002Human non-small cell lung tumors and cells derived from normal lung express both estrogen receptor alpha and beta and show biological responses to estrogenCancer Res6221412150PubMedGoogle Scholar
- Konstantinopoulos, PA, Kominea, A, Vandoros, G, Sykiotis, GP, Andricopoulos, P, Varakis, I, Sotiropoulou-Bonikou, G, Papavassiliou, AG 2003Oestrogen receptor beta (ERβ) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour’s dedifferentiationEur J Cancer3912511258CrossRefPubMedGoogle Scholar
- Fuqua, SA, Schiff, R, Parra, I, Moore, JT, Mohsin, SK, Osborne, CK, Clark, GM, Allred, DC 2003Estrogen receptor β protein in human breast cancer: correlation with clinical tumour parametersCancer Res6323432439Google Scholar
- Skliris, GP, Munot, K, Bell, SM, Carder, PJ, Lane, S, Horgan, K, Lansdown, MRJ, Parkes, AT, Hanby, AM, Markham, AF, Speirs, V 2003Reduced expression of oestrogen receptor β in invasive breast cancer and its re-expression using DNA methyltransferase inhibitors in a cell line modelJ Pathol201213220CrossRefPubMedGoogle Scholar
- Speirs V, Carder PJ, Lane S, Dodwell D, Lansdown MRJ, Hanby AM: Oestrogen receptor β: what it means for patients with breast cancer. Lancet Oncol 5: 174–181, 2004 (Erratum in: Lancet Oncol 5: 208, 2004).Google Scholar